Sun Pharmaceutical Industries Limited — Others, 21-01-2025: Shareholders meeting

Sun Pharmaceutical Industries Limited has announced a board meeting to discuss and approve a Composite Scheme of Arrangement involving the amalgamation of several wholly-owned subsidiaries with the company. The meeting took place via video conferencing, with Mr. Dhirendra Sinha serving as Chairperson. The scheme has received the necessary majority approval from equity shareholders and is expected to enhance operational efficiency and streamline operations. This development could foster a positive outlook among investors, reflecting a commitment to strategic growth and consolidation within the company.